Pharmafile Logo

bosentan

Deal Watch table for June 2013

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

- PMLiVE

J&J files ‘breakthrough’ drug ibrutinib in US

FDA to assess drug in lymphoma and leukaemia

- PMLiVE

AstraZeneca boosts R&D prospects with Pearl acquisition

Deal to acquire respiratory firm could be worth up to $1.15bn

Pharma deals during May 2013

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Deal Watch table for May 2013

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

- PMLiVE

GSK buys rights to MorphoSys’ arthritis antibody

Pharma company will pay up €445m to develop and commercialise MOR103

- PMLiVE

Talking about a successful merger

How communications can support effective mergers and acquisitions outcomes

- PMLiVE

AstraZeneca offers $443m to buy Omthera

Adds to list of deals to boost flagging pipeline

- PMLiVE

A look back at Sanofi’s merger with Synthélabo

This month, in 1999: How two pharma companies came together to create a giant

- PMLiVE

Actavis to buy Warner Chilcott in $8.5bn deal

Combined company will have annual revenues of about $11bn

Bayer symbol

Bayer boosts consumer care business with Steigerwald purchase

Fuels ambition to become world leader in OTC medicines

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links